Northeast Financial Consultants’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-1,814
Closed -$201K – 370
2022
Q1
$201K Sell
1,814
-1,024
-36% -$108K 0.01% 371
2021
Q4
$294K Sell
2,838
-232
-8% -$26.9K 0.02% 282
2021
Q3
$385K Sell
3,070
-623
-17% -$80.6K 0.03% 251
2021
Q2
$458K Buy
3,693
+600
+19% +$75.3K 0.03% 231
2021
Q1
$365K Buy
3,093
+232
+8% +$27.2K 0.03% 243
2020
Q4
$335K Hold
2,861
– – 0.03% 241
2020
Q3
$297K Sell
2,861
-12
-0.4% -$1.21K 0.03% 231
2020
Q2
$263K Buy
2,873
+6
+0.2% +$575 0.03% 234
2020
Q1
$259K Buy
2,867
+6
+0.2% +$638 0.03% 216
2019
Q4
$325K Sell
2,861
-1,019
-26% -$112K 0.03% 225
2019
Q3
$421K Hold
3,880
– – 0.04% 196
2019
Q2
$378K Buy
3,880
+23
+0.6% +$2.1K 0.04% 204
2019
Q1
$351K Buy
+3,857
New +$345K 0.04% 208
2018
Q3
– Sell
-2,585
Closed -$221K – 164
2018
Q2
$221K Hold
2,585
– – 0.07% 129
2018
Q1
$207K Sell
2,585
-262
-9% -$21.6K 0.07% 134
2017
Q4
$229K Buy
2,847
+262
+10% +$21K 0.08% 132
2017
Q3
$201K Hold
2,585
– – 0.07% 146
2017
Q2
$229K Hold
2,585
– – 0.09% 131
2017
Q1
$208K Buy
+2,585
New +$202K 0.09% 139
2016
Q4
– Sell
-2,585
Closed -$223K – 151
2016
Q3
$223K Buy
+2,585
New +$225K 0.09% 139

Other funds holding MDT

Northeast Financial Consultants's MDT Position: Q2 2022 in Review

Northeast Financial Consultants sold out of Medtronic (MDT) in Q2 2022, closing a stake of 1,814 shares — an estimated $201K sold.

Northeast Financial Consultants first reported a position in MDT in Q3 2016 and held it in 20 quarters. The position peaked at $458K in Q2 2021. 2,022 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • Northeast Financial Consultants reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
  • Northeast Financial Consultants sold 1,814 Medtronic shares in Q2 2022, an estimated $201K.
  • Northeast Financial Consultants first reported a position in Medtronic in Q3 2016 and held it in 20 quarters.
  • Northeast Financial Consultants's Medtronic position peaked at $458K in Q2 2021.
  • 2,022 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Northeast Financial Consultants's 13F filing for Q2 2022, filed 12 Aug 2022.